A research team at the HUN-REN (Hungarian Research Network) Biological Research Centre, Szeged has described a previously uncharacterized mechanism by which certain bacteriophages — viruses that infect bacteria, not human cells — can attach directly to human intestinal epithelial cells. The work, from the Centre’s Translational Microbiology Laboratory at the Institute of Biochemistry, was published in Nature Communications in 2026 and is authored by Gábor Apjok and Tóbiás Sári as co-first authors, with Apjok and group leader Bálint Kintses as co-corresponding authors.
The study is a useful data point for anyone tracking research output outside the US-heavy publishing mix: it is a Hungarian, HUN-REN-affiliated finding built on gut-microbiome and phage-biology work that has been accumulating in Central European labs for several years, and it lands in a high-visibility Nature-family journal rather than a specialty phage-therapy outlet.
What the researchers found
Certain bacteriophages carry surface adhesion proteins that function as “molecular anchors,” allowing them to bind to human intestinal epithelial cells. Because phages are strictly bacteria-infecting viruses, this binding is adhesion, not infection — the phages do not replicate inside or infect the human cells they attach to. The team demonstrated the mechanism was transferable: by engineering the relevant adhesion-protein genes into phages that normally do not adhere to human cells, they conferred the same binding capability, and the engineered phages persisted longer in the intestines of mice without infecting host tissue.
At the cellular level, the attached phage particles are taken up by the epithelial cells through vesicle-mediated internalization and trafficked into the endoplasmic reticulum. The researchers also observed that small structural differences between adhesion-protein variants change how strongly and how specifically a given phage binds — a distinction that matters for anyone trying to engineer this behavior deliberately rather than rely on it occurring naturally.
The gut-microbiome connection
The team also looked at where adhesion-competent phages — those carrying the anchor-conferring adhesion proteins — actually turn up in real gut communities. These phages were more prevalent in gut samples from healthy individuals than in samples from people with inflammatory bowel disease (IBD), suggesting an association between this anchoring capacity and an intact, healthy intestinal mucosa. That correlational finding doesn’t establish a causal or protective role on its own, but it gives the mechanism a plausible physiological context beyond the lab bench.
Why it matters: two distinct therapeutic angles
- More targeted phage therapy. Phage therapy — using bacteriophages to kill specific pathogenic bacteria — is an active area of research as an adjunct or alternative to antibiotics, particularly for resistant infections. A controllable adhesion mechanism that lets engineered phages persist longer at a target site in the gut could improve how precisely and how long a therapeutic phage stays where it’s needed.
- Intracellular delivery vehicles. Because the internalization pathway routes phage particles into the endoplasmic reticulum, the researchers point to a second, more exploratory application: repurposing engineered phages as delivery vehicles for conditions tied to endoplasmic-reticulum function, citing cystic fibrosis as an example of the kind of disease this route could eventually be relevant to.
Both applications are early-stage extrapolations from a mechanistic and murine-model finding, not clinical results, and the researchers frame them as future directions the anchor mechanism “may later prove important” for, rather than as established therapies.
In the researchers’ own words
Co-first and co-corresponding author Gábor Apjok, describing the significance of the anchoring mechanism, was quoted as saying: “They are not becoming human viruses; rather, they use molecular anchors that may later prove important in designing more targeted phage therapies.”
Why this belongs in a global research-tracking picture
For research administrators and anyone building a picture of where significant microbiome and phage-biology output originates, this finding is a reminder that the field is not concentrated in a handful of large US research-intensive universities. HUN-REN — Hungary’s national public research network, formed from the reorganized Hungarian Academy of Sciences research institute system — runs the Biological Research Centre in Szeged as one of its flagship life-science institutes, and this publication is a direct output of that network landing in a leading international journal. Tracking non-US-origin findings like this one matters for accurate research information systems coverage and for anyone using CRIS platforms to map global collaboration and output beyond the most heavily indexed institutions.
What to watch next
As with any single mechanistic paper, the next steps that will determine real-world relevance are independent replication, whether the adhesion-anchor approach can be engineered reliably into clinically relevant phage candidates, and whether the healthy-versus-IBD association holds up in larger, more diverse cohorts. None of that has been reported yet as of this writing; this article covers only what the HUN-REN team has published to date.
